The year 2024 marks an important milestone for Swixx, as we celebrate 10 years of our operations. While we have, evolved to become one of the leading pharma commercialization platforms over the past decade, we remained committed to our vision of creating a healthier future for all by unlocking access to innovative medicines for all patients who need them.
Our vision was the foundation for the development of Swixx’s ESG strategy framework, created by a dedicated internal team throughout 2024. The framework reflects our responsible, compliant, sustainable, and ethical vision of our current and future business practices.
The starting point of the framework was the performance of a double materiality assessment through a comprehensive stakeholder engagement. We have engaged with >130 internal colleagues, performed 2 in-depth partner interviews and analyzed 13 on-line ESG surveys to ensure that our ESG direction resonates with expectations, as well as reflects our mission.
Swixx’s ESG framework underscores our dedication to environmental stewardship, social responsibility, and governance excellence across five ESG building blocks aligned with the UN Sustainable Development Goals. We are committed to contributing to global objectives while transparently reporting on our ESG progress:
This framework sets the stage for our upcoming detailed ESG report, transparently communicating our company's commitments, goals, progress, and milestones. Conscious of global efforts to integrate ESG in our business, we are dedicated to making a positive impact for our partners, patients, and communities.
Swixx ESG Framework
Swixx Biopharma AG
Neuhofstrasse 5A
CH-6340 Baar
Switzerland
Tel. +41 41 5523 440
info@swixxbiopharma.com
Hybernská 5, 11000 Praha 1
Czech Republic
Tel. +420 242 434 242
info@swixxbiopharma.com